-+ 0.00%
-+ 0.00%
-+ 0.00%

Collumbotai Biotech announced in Hong Kong that our partner WindwardBioAG has announced that SKB378/Win378 achieved positive interim results in phase 2 of the Polaris-1 clinical trial for asthma treatment. Phase 3 of POLARIS-1 has also started.

智通財經·09/08/2026 12:09:27
語音播報
Collumbotai Biotech announced in Hong Kong that our partner WindwardBioAG has announced that SKB378/Win378 achieved positive interim results in phase 2 of the Polaris-1 clinical trial for asthma treatment. Phase 3 of POLARIS-1 has also started.